Literature DB >> 29364302

Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats.

Rosario Martínez1, Garyfallia Kapravelou, Ana Donaire, Carlos Lopez-Chaves, Francisco Arrebola, Milagros Galisteo, Samuel Cantarero, Pilar Aranda, Jesus M Porres, María López-Jurado.   

Abstract

Metabolic syndrome is a cluster of metabolic alterations characterized by central obesity, dyslipidemia, elevated plasma glucose, insulin resistance (IR) and non-alcoholic fatty liver disease (NAFLD). In this study, a combined intervention of a lentil protein hydrolysate and a mixed training protocol was assessed in an animal experimental model of genetic obesity and metabolic syndrome. Thirty-two male obese and 32 lean Zucker rats were divided into eight different experimental groups. Rats performed a mixed exercise protocol or had a sedentary lifestyle and were administered a lentil protein hydrolysate or placebo. Daily food intake, weekly body weight gain, plasma parameters of glucose and lipid metabolisms, body composition, hepatic weight, total fat content and fatty acid profile, as well as gene expression of lipogenic and lipolytic nuclear transcription factors and their target genes were measured. Obese Zucker rats exhibited higher body and liver weight and fat content than did their lean counterparts. Such alterations were related to modifications in aerobic capacity, plasma biochemical parameters of glucose and lipid metabolisms, hepatic fatty acid profile and gene expression of nuclear transcription factors SREBP1c, PPARα, LXR and associated lipogenic and lipolytic enzymes. The interventions tested did not affect body weight gain but improved aerobic capacity, reduced hepatomegalia and steatosis associated with NAFLD and relieved the adverse effects produced by this condition in glucose and lipid metabolisms through the modulation in the expression of different genes involved in diverse metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29364302     DOI: 10.1039/c7fo01790a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  5 in total

Review 1.  Health Benefits of Cereal Grain- and Pulse-Derived Proteins.

Authors:  Jenny Bouchard; Maneka Malalgoda; Joanne Storsley; Lovemore Malunga; Thomas Netticadan; Sijo Joseph Thandapilly
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

2.  In Vivo Nutritional Assessment of the Microalga Nannochloropsis gaditana and Evaluation of the Antioxidant and Antiproliferative Capacity of Its Functional Extracts.

Authors:  Rosario Martínez; Alejandro García-Beltrán; Garyfallia Kapravelou; Cristina Mesas; Laura Cabeza; Gloria Perazzoli; Palmira Guarnizo; Alberto Rodríguez-López; Roberto Andrés Vallejo; Milagros Galisteo; Pilar Aranda; Jose Prados; María López-Jurado; Consolación Melguizo; Jesus M Porres
Journal:  Mar Drugs       Date:  2022-05-11       Impact factor: 6.085

3.  High oleic peanuts improve parameters leading to fatty liver development and change the microbiota in mice intestine.

Authors:  Elise Taieb Bimro; Ran Hovav; Abraham Nyska; Tal Assa Glazer; Zecharia Madar
Journal:  Food Nutr Res       Date:  2020-08-28       Impact factor: 3.894

4.  Anemonia sulcata and Its Symbiont Symbiodinium as a Source of Anti-Tumor and Anti-Oxoxidant Compounds for Colon Cancer Therapy: A Preliminary in Vitro Study.

Authors:  Laura Cabeza; Mercedes Peña; Rosario Martínez; Cristina Mesas; Milagros Galisteo; Gloria Perazzoli; Jose Prados; Jesús M Porres; Consolación Melguizo
Journal:  Biology (Basel)       Date:  2021-02-08

5.  Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats.

Authors:  Luisa M Lopez Trinidad; Rosario Martinez; Garyfallia Kapravelou; Milagros Galisteo; Pilar Aranda; Jesus M Porres; Maria Lopez-Jurado
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.